As we continue to monitor the COVID-19 pandemic, our thoughts are with our Members and those impacted. We recognize that the ever-changing impact of this novel virus is disruptive to so many aspects of our personal and professional lives. We are not...
Last Updated: 25 March 2020 As we continue to monitor the global COVID-19 public health emergency, our thoughts are with our Members and those impacted. We recognize that the ever-changing nature of this novel virus is...
One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient...
ISPE places the health and safety of its members, staff, and the broader ISPE global community as its top priority. As the COVID-19 outbreak continues, the ISPE Drug Shortages Initiatives Team encourages everyone to follow the available safety and health...
The pharmaceutical industry’s work on developing treatments and vaccines for COVID-19 (novel coronavirus) is moving forward, including these recent developments:
Gilead’s remdesivir treatment is in clinical trial in China, and the company announced it...
In April 2010, the Eyjafjallajökull volcano in Iceland erupted for six days, wreaking havoc on air travel and supply chain activities across western and northern Europe for a month. Many companies were caught off guard, resulting in industry-wide...
Updated 3 March, 2020 ISPE is closely monitoring the evolution of the Coronavirus situation and we are following the World Health Organization (WHO) guidance and travel advice. Every precaution is being taken to ensure the health and safety of our...
